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Abstract
Background: Dengue, transmitted primarily by the bites of infected Aedes aegypti L., is transmitted to millions of
individuals each year in tropical and subtropical areas. Dengue control strategies are primarily based on controlling
the vector, using insecticides, but the appearance of resistance poses new challenges. Recently, highly selective
protease inhibitors by phage display were obtained for digestive enzymes of the 4th instar larvae (L4) midgut.
These mutants were not confirmed as a larvicide due to the low yield of the expression of these inhibitors. In the
present study, chimera molecules were constructed based on the mutations at positions P1-P4’ selected previously.
The T6, T23 and T149 mutants were mixed with another Kunitz inhibitor, domain 1 of the inhibitor boophilin (D1).
Methods: The chimeras T6/D1, T149/D1 and T23/D1 were expressed at high levels in P. pastoris yeast, purified by
ionic exchange chromatography and their homogeneity was analyzed by SDS-PAGE. The chimera inhibitors were
assayed against larval trypsin, chymotrypsin and elastase using specific chromogenic substrates. The inhibitors were
assayed for their larvicide potential against L4.
Results: The chimeras exhibited strong inhibitory activities against the larval digestive enzymes in a dose-dependent
manner. T6/D1, T149/D1 and T23/D1 exhibited strong larvicidal activity against L4 of Ae. aegypti with inhibitor
concentrations in the μM range. A synergistic increase in mortality was observed when a mixture of the three
chimeric inhibitors was tested.
Conclusions: The strategy for constructing the chimeric inhibitors was successful. The chimeras showed strong
larvicidal activity against Ae. aegypti. In the future, our findings can be used to design synthetic inhibitors for larvae
digestive enzymes as an alternative method to control the dengue vector.
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Background
Aedes aegypti (Linnaeus) is the primary vector of several
arboviruses including dengue, yellow fever and chikun-
gunya [1, 2]. Aedes aegypti is well adapted to urban areas,
and represents a major problem for public health [2]. An
estimated 500,000 people with severe dengue are hospital-
ized each year, and approximately 2.5 % die [3]. Unfortu-
nately, there is no vaccine or treatment for dengue
available, and vector reduction remains the main method
for reducing the transmission of the dengue virus [3].
Digestive enzymes present in Ae. aegypti larvae include
trypsin-like, chymotrypsin-like and elastase-like serine
proteases [4]. A transcriptional analysis of the trypsin-
like enzymes present in the midgut of laboratory-reared
Ae. aegypti was performed, and the key enzyme, a native
trypsin, was purified and characterized [4].
The trypsin inhibitor from Moringa oleifera flowers
(MoFTI) interferes with the survival and development of
Ae. aegypti larvae. Mortality of newly hatched larvae
(L1) was observed in the presence of the M. oleifera
flower extract and MoFTI [5]. A lectin from M. oleifera
* Correspondence: tanaka.bioq@epm.br
1Departamento de Bioquímica, Escola Paulista de Medicina, Universidade
Federal de São Paulo, Rua 3 de Maio 100, 04044-020 São Paulo, SP, Brazil
Full list of author information is available at the end of the article
© 2015 Soares et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Soares et al. Parasites & Vectors  (2015) 8:511 
DOI 10.1186/s13071-015-1127-4
seeds (WSMoL) was shown to kill Ae. aegypti L4 by
causing morphological alterations in the digestive tract
and inhibition the digestive enzymes [6].
Recently, phage display was performed using a selection
of inhibitors to the larvae digestive enzymes [7]. A library
of mutants was constructed using the inhibitor HiTI as a
template, and the reactive site region, P1 to P4', of the
inhibitor was randomized. The HiTI mutants that showed
strong inhibitory activity were T6 for trypsin and T23 and
T149 for both chymotrypsin and elastase. As the HiTI
mutants’ expression in yeast was very low, it was not
possible to evaluate their larvicidal activity.
The strategy adopted in this work was to insert the
mutations at positions P1 to P4' of HiTI, T6, T23, and
T149, into domain 1 of the thrombin inhibitor boophilin
[8], which exhibited high levels of expression in P. pas-
toris yeast. The new chimera molecules were designated
mutants T6/D1, T23/D1, and T149/D1 and were pro-
duced and tested as larvicide for Ae. aegypti larvae. As
the mosquito larvae is confined to and continuously
feeds in aquatic environments [9], inhibition of the
digestive enzymes present at this stage of life could be a
useful strategy to control the mosquito populations.
Methods
Cloning and expression of the inhibitors in Pichia pastoris
For this work, we constructed chimeric inhibitors in
which the region P1-P4’ of the selected inhibitors by
phage display previously [7] was cloned substituting this
region in the domain 1 of the boophilin inhibitor (D1)
(Fig. 1), which has a high level of protein expression. As
the boophilin inhibitor domain 1 (D1 wild) had been cloned
previously in our laboratory in pPICZαB plasmid this
construction D1 wild/pPICZαB was used as a template for
PCR reactions. To replace the P1-P4’ region (reactive site)
of the inhibitor boophilin D1 by this region of the inhibitors
T6, T23 and T149, were designed internal oligonucleotides
flanking this region for each inhibitor. The internal oligonu-









CAGATGCCTTG-3’. The DNA amplifications by PCR
were performed in two steps: firstly, DNA was amplified
the initial region of the inhibitors until the reactive site
containing the substitutions (AOX5’ and D1IntRv oligonu-
cleotides), and secondly, it was amplified the region of the
reactive site containing the substitutions until the end of
the inhibitors (D1IntFw and AOX3’ oligonucleotides),
construction D1 wild/pPICZαB was the template for both.
Afterwards, the two DNA fragments were united by a PCR
reaction using primers AOX5’ and AOX3' flanking region
of the initial and end of the inhibitors, this procedure was
made to each mutant. Purified DNA fragments were
digested with XhoI and NotI restriction enzymes and ligated
into the pPICZαB vector, (Invitrogen, Carlsbad, CA, EUA)
previously digested with the same restriction enzymes. The
resulting constructs were used in the transformation of
bacteria E. coli DH5-α, purified, sequenced and verified.
The constructs were used to transform yeast P. pastoris
strain GS115 by electroporation. To identify positive yeast
clones expressing each of the inhibitors, five clones from P.
pastoris strain GS115 containing the insert of each inhibi-
tor, identified and verified by PCR (AOX5’ and AOX3’
oligonucleotides), were individually inoculated in 2.5 mL of
BMGY medium (Buffered Glycerol-complex Medium)
(1.0 % (w/v) yeast extract, 2.0 % (w/v) peptone in 100 mM
potassium phosphate buffer, pH 6.0, 1.34 % (w/v) YNB, 4 ×
10−5% (w/v) biotin and 1 % (v/v) glycerol) in a 50 mL sterile
tube and incubated at 30 °C for 28 h at 250 rpm. The yeast
cells were harvested by centrifugation at 3000 × g for 5 min
at 4 °C, and resuspended in BMMY medium (Buffered
Methanol-complex Medium) (BMGY with glycerol re-
placed by 0.5 % (v/v) methanol) to an absorbance of 1.0 at
600 nm. Proteins were expressed at 30 °C with shaking at
250 rpm, for 96 h with the addition of 0.5 % (v/v) methanol
every 24 h. After removing the cells by centrifugation
(4000 × g for 20 min at 4 °C), the supernatants were
assessed for their ability to inhibit bovine chymotrypsin,
bovine trypsin or neutrophil elastase using enzymatic assays
and the following specific chromogenic substrates: Tosyl–
Gly–Pro–Arg–pNA for trypsin, Suc–Ala–Ala–Pro–Phe–
pNA for chymotrypsin and Suc–Ala–Ala–Pro–Val–pNA
for elastase. Individual clone expressing high levels of each
inhibitor was selected. A single P. pastoris colony (Mut+)
expressing high level of the mutants T6/D1, T23/D1 T149
and D1 wild was selected and used to inoculate 120 mL of
BMGY medium in a 1 L sterile flask, which was
then further incubated at 30 °C and 250 rpm for
24 h. Protein expression was performed as described
above, and the supernatant of the culture was stored
at −20 °C.
Purification of the inhibitors T6/D1, T23/D1, T149/D1 and
D1 wild
The expression supernatants (~1 L) of the inhibitors T6/
D1, T23/D1, T149/D1 and D1 wild were dialyzed with
0.04 M Tris–HCl, pH 8.0, and applied to ion exchange
chromatography on HiTrap Q column. The inhibitors
(~200 mL supernatant per chromatography) were puri-
fied using ion exchange chromatography on HiTrap Q
column (GE, Fairfield, CT, EUA), connected to a
medium pressure chromatography system ÄKTA Prime,
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previously equilibrated with 0.05 M Tris–HCl, pH 8.0.
After washing, the proteins were eluted using a NaCl
linear gradient (0–1 M) in 0.05 M Tris–HCl, pH 8.0, at
flow rate 1.5 mL / min for 60 min. Flow through and
eluted fractions from the HiTrap Q column were tested
for inhibitory activities to trypsin (T6/D1 and wild D1)
and elastase (T23/D1 and T149/D1) using the chromo-
genic substrates Tosyl-Gly-Pro-Arg-pNA, and Suc-
Ala-Ala-Pro-Val-pNA, respectively. Purified inhibitors
were concentrated and analyzed by 15 % SDS-PAGE
gels [10].
Larvicidal activity assay using the mutants T6/D1, T23/D1,
T149/D1 and D1 wild
Adult Ae. aegypti colonies (Rockefeller strain) were
reared in cages, at 27 °C and provided of 10 % sucrose
solution in distilled water. A glass container filled with
distilled water was kept inside each cage to maintain the
humidity. Larvae were maintained in distilled water and
fed on a minced commercial mouse food. The fourth
(L4) instar larvae were used in the experiments. For the
assay, groups of 15 L4 were placed in 5 mL of distilled
water containing the following total protein concen-
trations of the mutants T6/D1 (111–588 μM), T23/D1
(79–858 μM), T149/D1 (64–684 μM) and D1 wild
(64–684 μM). The lethal concentrations required for
killing 50 % of Ae. aegypti larvae (LC50) after 24 and
48 h were calculated by probit analysis with a reliabil-
ity interval of 95 % using the StatPlus 2006 software
(AnalystSoft, Vancouver, BC, Canada). The experiments
were performed in triplicate and monitored at 24 h and
48 h. ANOVA (p < 0.05) and the Tukey's test used in the
statistical analysis were calculated using GraphPad Prism
version 4.0 for Windows (GraphPad Software, San Diego,
CA, USA).
Inhibitory activity assay of mutant inhibitors T6/D1, T23/
D1, T149/D1 for larvae serine proteases
Larvae midgut extract (0.8 mg total protein was used for
trypsin and chymotrypsin and 24.5 mg for elastase) was
pre incubated with different concentrations of the inhibi-
tors T6/D1, T23/D1, T149/D1 in 0.1 M Tris/HCl (pH 8.0)
containing 0.1 % Triton X-100 for 10 min at 37 °C. After-
wards, residual enzymatic activities were measured at
405 nm by adding Suc-Ala-Ala-Pro-Val-pNA, Tosyl-Gly-
Pro-Arg-pNA and Suc-Ala-Ala-Pro-Phe-pNA as chromo-
genic substrates for neutrophil elastase, trypsin and
chymotrypsin, respectively.
Results
Cloning, expression and purification of the chimeric
inhibitors
Amino acids at positions P1-P4' of D1 (KALIP) were
replaced by the amino acids presented at those positions
in the mutants T6 (RGGAV), T23 (LLGGL) and T149
(GGVWR), selected previously by phage display. The
nucleotide sequences of T6/D1 (Fig. 2a), T23/D1
(Fig. 2b), and T149/D1 (Fig. 2c) clones in the pPIZαB
Fig. 1 The strategy for the construction of the chimeric inhibitors sequences using the construction of the inhibitor boophilin domain 1 (D1) in
pPICZαB plasmid as a template. Nucleotides sequence of wild D1, the region used to construct internal oligonucleotides is represented by left right
arrow. Sequence nucleotides and amino acids in region P1-P4’ of the D1 inhibitor that was replaced in production of mutants are shaded in gray.
AOX5’ is the primer forward present in plasmid pPICZαB and AOX3’ the reverse primer. The internal primer to construct the mutants were designer in
the same place, the internal reverse primer is matched with AO5’ in PCR reaction to form the first part of the inhibitor and internal forward primer is
matched with AOX3’ to form the second part of the inhibitor, this parts were joined by a PCR reaction using the AOX5’and AOX3’ primers
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vector were confirmed by PCR amplification followed
by DNA sequencing. Mutants T6/D1 (Fig. 3a), T23/
D1 (Fig. 3b), T149/D1 (Fig. 3c) and wild D1 (Fig. 3d)
were purified by ion exchange chromatography and by
SDS-PAGE confirmed the homogeneity of the inhibitors
(Fig. 4a).
Inhibitory activity of the mutants for larval serine proteases
All mutants showed inhibitory activity against larvae di-
gestive enzymes in a dose-dependent manner (Fig. 4b).
T6/D1 was able to inhibit larval trypsin-like enzymes,
and T23/D1 and T149/D1 both inhibit chymotrypsin-
like and elastase-like enzymes.
Fig. 2 Nucleotides and traduced amino acid sequences of the chimera cloned in the pPICZαB vector. a. Mutant T6/D1; b. Mutant T23/D1; c. Mutant
T149/D1. The sequence of pPICZαB vector is underlined, and the mutated regions (P1-P4’) of the inhibitors are shown in gray
Fig. 3 Purification of the chimeras T6/D1, T149/D1, T23/D1 and D1 wild expressed in P. pastoris by ion exchange chromatography in HiTrap Q column.
The supernatant of the culture medium dialyzed with 0.05 M Tris/HCl pH 8.0 buffer was applied in the column pre equilibrated with the same buffer. The
elution of proteins was performed with a linear gradient of NaCl (0–1 M). The regions containing inhibitory activities are indicated by gray arrows
Soares et al. Parasites & Vectors  (2015) 8:511 Page 4 of 8
Larvicidal assays using mutants T6/D1, T23/D1, T149/D1
and wild D1
Larvicidal potential of the mutant inhibitors and wild
D1 were evaluated on L4 larvae. The mutant T6/D1
showed 100 % of mortality against L4 at 350 μM after
24 h. At 302 μM, mutant T6/D1 showed approximately
40 % mortality in L4 larvae after 48 h (Fig. 5a). The LC50
values determined for T6/D1 were of 380 μM and 302 μM
for larvae after 24 h and 48 h of assay, respectively. The
mutant T23/D1 presented mortality of 35-95 % in concen-
trations between 604 μM to 858 μM, at 48 h (Fig. 5b). The
LC50 values for T23/D1 were of 1.1 mM and 611 μM for
larvae after 24 h and 48 h, respectively. At 24 h, the
mutant T149/D1 showed 18-80 % mortality of L4 larval
between the concentrations 413 μM to 684 μM. At 48 h,
mortality increased to 60-100 % (Fig. 5c). The LC50 values
for T149/D1 were of 577 μM and 421 μM for larvae after
24 h and 48 h, respectively. A synergic effect was observed
when mutant T6/D1 (238 μM), T23/D1 (198 μM) and
T149/D1 (286 μM) were mixed together and tested
against L4 Ae. aegypti larvae, at concentrations that
individually none of the inhibitors presented larvicidal
effect, all together showed 100 % mortality (Fig. 5e).
The wild D1 showed larval mortality of 27-93 % at
270 μM to 684 μM, respectively at 24 h. The estimated
LC50 for D1 were of 474 μM for larvae after 24 h. At
48 h, the L4 mortality was 60-100 % (Fig. 5d). All inhibi-
tors were used in assays against L1, at the same concen-
trations used in the assays for L4 Ae. aegypti larvae, but
larvicidal activity was not observed (data not showed).
Discussion
The advance in integrated pest management has been
caused by most cost-effective methods and common-
sense practices for control of pests that represent a low
hazard to the environment and people [11]. Phage
display is a powerful technique used to study protease
inhibitors [12–14]. Recently, our group used phage dis-
play system and the inhibitor HiTI [15] to select specific
inhibitor for digestive enzymes of Ae. aegypti larvae [7].
In this work, based on data of Soares et al. [7], the mu-
tated regions (residues P1-P4’) of selective HiTI mutated
Fig. 4 Characterization of the mutants: T6/D1, T23/D1, T149/D1 and D1 wild. a SDS–PAGE (15 %) of the flow through of the ion exchange
chromatography in HiTrap Q column of the mutants T6/D1, T23/D1, T149/D1 and D1 wild. b Inhibition assay of the chimeric inhibitors for larvae
serine proteases. Enzymatic activities using the L4 midgut extract of Ae. aegypti and chromogenic substrate for trypsin (Tosyl-Gly-Pro-Arg-pNA),
chymotrypsin (Suc-Ala-Ala-Pro-Phe-pNA) and elastase (Suc-Ala-Ala-Pro-Val-pNA). Both trypsin and chymotrypsin assays were performed using
0.8 mg total protein, and 24.5 mg total protein for elastase
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inhibitors identified for digestive enzymes Ae. aegypti
larvae were inserted into another Kunitz domain inhibi-
tor, to increase the level of recombinant protein expres-
sion. The template inhibitor selected was the boophilin
inhibitor domain 1 (D1) of Rhipicephalus microplus.
Previously, boophilin domain 1 had been cloned and
expressed by our group and shown to a high protein
expression level of approximately 20 mg/L [8]. The
chimeric molecules, named mutants HiTI T6, T23 and
T149, were selected by strong inhibition activity of
digestive enzymes of Ae. aegypti larvae, presenting IC50
in nM range [7].
The continuous and indiscriminate use of synthetic
insecticides has led to emergence resistant Ae. aegypti
populations, environmental persistence and unselective
toxicity [16]. Natural insecticides have been investigated
for larvicidal effect on Ae. aegypti resistant strains
because they are usually available at low cost, are usually
highly biodegradable, and the larvae usually do not
develop cross-resistance to them, minimizing resistance
Fig. 5 Larvicidal effect of chimeric inhibitors against L4 Ae. aegypti larvae, in 24 h and 48 h assays. a. Mutant T6/D1; b. Mutant T23/D1; c. Mutant
T149/D1; d. D1 wild; e. Assay with combination of the mutants T6/D1, T23/D1 and T149/D1. The experiments were performed in triplicate using
experimental group containing 15 larvae each. The larval mortality level of the inhibitors was significant increase when compared to control (*p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001 and ns-not significant, in Tukey’s Multiple Comparison Test). ANOVA (p≤ 0.05) and Tukey's analysis were used for
statistical analysis. Error bars correspond to the standard error of the mean of three experiments
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development [17]. Thus, alternative methods and new
strategies for vector control need to be developed. Puri-
fied proteins from plants have been demonstrated larvi-
cidal activity against Ae. aegypti. Many plant insecticides
primarily target the midgut of the mosquito larvae, and
some are able to interfere with the larval development
into adult stage. A trypsin inhibitor (MoFTI) purified
from Moringa oleifer flowers caused mortality of hatched
newly larvae [5]. And, a lectin extracted from M. oleifera
seeds (WSMoL) was able to kill L4 Ae. aegypti by
causing morphological alterations in the larvae digestive
tract and inhibition digestive enzymes [6]. A lectin from
Myracrodruon urundeuva leaf showed effect on survival
and digestive enzymes activity from Ae. aegypti larvae
[18]. Essential oils from Brazilian Croton species showed
larvicidal activity against Ae. aegypti [16]. So, the produc-
tion of highly selective inhibitors for the digestive enzymes
from Ae. aegypti larvae by mutagenesis presents itself as
an innovative approach in this area of study.
The enzymes present in the gut of larvae of Ae. aegypti
responsible for its digestion are trypsin-like, chymotrypsin-
like and elastase-like serine proteases [7, 19]. In the present
work, the mutant T6/D1, a trypsin inhibitor, in the concen-
tration of 350 μM caused the highest mortality (100 %) in
L4 Ae. aegypti. This results corroborate the data that, tryp-
sin is the major enzyme presents in the midgut of Ae.
aegypti, being the main responsible for digestion in larvae
[7] and the impairment of its activity may result in poor
nutrient absorption and non-availability of essential amino
acids. The mutant T23/D1, also showed larvicidal effect
against L4, but its effect was only observed after 48 h with
mortality rates of 50-93 %. The mutant T149/D1 showed
larval mortality of 60-100 % at 48 h of exposure. T149/D1
was more effective as larvicide than T23/D1. These data
support our hypothesis that T149/D1 may have been
selected not only to the digestive enzymes but also to other
molecules present in the larval midgut that are important
for the larvae larval physiology. As T23/D1 and T149/D1
are inhibitors of the chymotrypsin and elastase enzymes
that are apparently in low concentration in the larvae,
which are in consonance with lower larvicidal effect than
T6/D1.
In an attempt to evaluate the synergic effect in the
inhibition of all enzymes present in midgut, the three
mutants T6/D1, T23/D1 and T149/D1 were added in a
larvicidal assay. Surprisingly, the concentration of each
inhibitor used in the blend not caused mortality when
used separately, but in combination, they caused 100 % L4
mortality. Confirming that, the inhibitors efficiency was
higher when all digestive enzymes present in the midgut
were inhibited in the same time. None of the three mu-
tants presented larvicidal effect against L1 Ae. aegypti,
confirming the specific-targeting power of phage display
selection system to effect only L4 larval.
To remove any doubt regarding the specificity of the
inhibitors in the larvicidal assay, the wild D1 inhibitor
was used in the larvicidal experiments. However, only
wild D1 caused mortality of approximately 50 % of L4
compared with 100 % mortality obtained for the T6/D1
and not mortality for the T23/D1, at the same concen-
tration. D1 was used as a control since only its reactive
site was removed for construction of chimeras. As
inhibitor D1 wild is a strong bovine trypsin inhibitor, it
was expected some effect on larval survival, but the
results support our conclusion that the mutant selection
was specific for the 4th larval instar and that trypsin-like
enzymes are important for larval physiology.
For the first time highly selective inhibitors have been
selected specifically for digestive enzymes from Ae.
aegypti larvae. The chimeric inhibitors may have im-
paired digestive and absorption processes in the midgut
of Ae. aegypti larvae compromising their survival.
Conclusions
Our findings indicate that the mutants selection by
phage display were specific for the L4 Ae. aegypti. The
mutant inhibitors were efficient in causing larval mortal-
ity; and the synergism of mutant inhibitors selected for
different digestive enzymes was more effective as larvi-
cide. In the future, these inhibitors can be used in con-
trol measures for the larvae of Ae. aegypti mosquito.
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